Company intelligence / Profile preview

DTEC SEC

Littleport, United Kingdom

Ownership: Private
Development stage: Other

Overview

D-Tec is a biotechnology company specializing in the development and manufacture of rapid diagnostic tests and PCR-based kits for the detection of infectious diseases and environmental pathogens. Based in the United Kingdom, the company provides a range of diagnostic solutions primarily focused on the veterinary, food safety, and environmental monitoring sectors. D-Tec's product portfolio includes specialized assays for detecting pathogens such as Legionella and various agricultural diseases. Since its acquisition by Omega Diagnostics, the company has integrated its technical expertise into a broader global diagnostics framework, continuing to serve clinical and industrial laboratories worldwide.

Therapeutic areas: Infectious Diseases
Modalities: Diagnostic testPCR
Industry: Molecular Diagnostics

Beyond the preview

Go deeper on DTEC SEC.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on DTEC SEC.

Explore the full profile